NOVARTIS AG (NVSEF)
Clinical trial NCT04689828: completion date: 2026-09-30 → 2026-09-10.
Clinical trial NCT04689828: completion date: 2026-09-30 → 2026-09-10.
Clinical trial NCT06932588 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-07-01 3. primary completion date: 2026-06-01 → 2026-07-09 4. enrollment: 350 → 351 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07519772: enrollment: 200 → 280 participants.
Clinical trial NCT07600723: start date: 2026-07-15 → 2026-11-04.
Clinical trial NCT03706365: completion date: 2026-06-01 → 2026-12-01.
Clinical trial NCT05023382: status: ACTIVE_NOT_RECRUITING → COMPLETED.
Clinical trial NCT07469176: start date: 2026-08-15 → 2026-09-15.
Clinical trial NCT07081997: start date: 2026-04-16 → 2026-05-07.
Clinical trial NCT06190613 updates: 1. completion date: 2026-08-31 → 2026-12-31 2. primary completion date: 2026-08-31 → 2026-12-31 3. enrollment: 100 → 110 participants
Clinical trial NCT07659964 updates: 1. completion date: 2027-06-01 → 2026-12-01 2. primary completion date: 2027-06-01 → 2026-12-01 3. primary purpose: BASIC_SCIENCE → OTHER